It has been demonstrated that PD-L1 is expressed in both CD4+ and CD8+ T cells in the tumor microenvironment and that PD-L1+ T cells in the tumor microenvironment inhibit nearby PD-1+ T cells and promote macrophage tumor tolerance, allowing for excessive tumor progression [70]. The gene discussed is CD4; the disease is neoplasm.